DIRS.INFO The most relevant business & tech news

☆ The market is having knee-jerk reactions to Trump's picks. That could spell buying opportunities
▼ + stars: | 2024-11-21 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Big swaths of the market have pulled back since the Nov. 5 election. Vaccine makers and processed food companies suffered after Robert F. Kennedy Jr., a prominent vaccine skeptic, was tapped to lead the Department of Health and Human Services. Just this week, HSBC upgraded Moderna to buy from hold, saying that its "pipeline deserves more than the market is giving it credit for." BioNTech, which pulled back more than 5% this month, was identified by Evercore ISI this week as a buying opportunity. AbbVie and First Solar are two other stocks with strong upside potential, based on analysts' consensus price targets compiled by FactSet.

Persons: Donald Trump's, Robert F, Kennedy Jr, Elon Musk, Vivek Ramaswamy, Nanette Abuhoff Jacobson, Luke O'Neill, FactSet Organizations: Department of Health, Human Services, Defense, Department of Government, Hartford Funds, Catalyst, Alpha Fund, White House, Moderna, HSBC, Evercore ISI, RFK Jr Locations: China

☆ Stocks making the biggest moves premarket: Walmart, Lowe's, Super Micro Computer, BioNTech and more
▼ + stars: | 2024-11-19 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Walmart – The retail giant gained about 4% after posting fiscal third-quarter results that surpassed Wall Street's estimates. Although the company reported a top- and bottom-line beat in the fiscal third quarter, it estimates sales will fall year over year. Super Micro Computer — The server maker soared around 26% after announcing BDO as its new auditor. Super Micro also provided a plan to the Nasdaq on how it will stay in compliance with exchange's rules. Symbotic — The automation technology company surged 28.5% after beating expectations for revenue in the fourth fiscal quarter.

Persons: Young, Symbotic, AeroVironment, Donald Trump's, Robert F, Kennedy Jr, Blackwell, Sarah Min, Samantha Subin, Hakyung Kim, Sean Conlon, Brian Evans, Michelle Fox Organizations: Walmart, BDO, Ernst, Nasdaq, Revenue, Wall, BioNTech, ISI, Department of Health, Human Services, Nvidia —, Nvidia

☆ Evercore ISI upgrades BioNTech, says 'chaos' of RFK Jr.'s nomination presents buying opportunity
▼ + stars: | 2024-11-19 | by ( Sean Conlon | ) www.cnbc.com time to read: +1 min

Now may be the time for investors to buy shares of BioNTech , according to Evercore ISI. On Monday, his cousin, Caroline Kennedy called his views on vaccines "dangerous" and said they're rejected by his family. This "chaos," however, presents a buying opportunity for investors, Evercore ISI Cory Kasimov wrote Tuesday. "The u/g call is a combination of opportunism, value (both relative & absolute), and an increasingly compelling fundamental outlook around the company's deep and staggered oncology pipeline." Analysts are mostly bullish on the stock, with 13 of 19 rating it a strong buy or buy rating, per LSEG data.

Persons: Donald Trump, Robert F, Kennedy Jr, Kennedy, Covid, Caroline Kennedy, they're, Cory Kasimov, Kasimov, It's Organizations: ISI, Department of Health, Human Services, Analysts Locations: BioNTech

☆ Here are Tuesday's biggest analyst calls: Nvidia, Apple, Meta, Uber, Netflix, Apollo, Datadog & more
▼ + stars: | 2024-11-19 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Morgan Stanley reiterates Apple, Microsoft and Meta as overweight The firm says "mega-cap tech under-ownership narrows" in the third-quarter but that it's sticking with all three stocks. " UBS upgrades Comfort Systems to buy from neutral UBS says the HVAC company is a beneficiary in tech and data center cooling. UBS upgrades American Water Works to buy from neutral UBS says it sees "consistent" total returns for the water company. " Jefferies reiterates Netflix as buy The firm raised its price target on the stock to $1,000 per share from $800. TD Cowen names Datadog a best idea The firm says the stock is a top idea in 2025.

Persons: Stifel, it's, Morgan Stanley, Okta, –, Jefferies, Uber, Needham, Joby, Piper Sandler downgrades Kraft Heinz, Piper, Kraft Heinz, Piper Sandler, Paul, Tyson, NFLX, TD Cowen, United, Datadog, Scott Thomson, it's bullish Organizations: Nvidia, Apple, Microsoft, Barclays, UBS, Comfort Systems, Works, Edison Electric, Kraft, Apollo, TAM, Netflix, Bank of America, Bank of, Scotiabank, JPMorgan Locations: Bank of Nova Scotia, robotaxis

☆ Four trades working this morning amid rising geopolitical tensions
▼ + stars: | 2024-11-19 | by ( Fred Imbert | ) www.cnbc.com time to read: +2 min

Geopolitics are raining on the stock market's parade, but other trades are working. U.S. stock futures fell Tuesday as tensions between Ukraine and Russia intensified. S & P 500 and Nasdaq-100 futures shed 1.1% each. That said, four trades are holding up against this backdrop: Gold futures rallied nearly 1% to around $2,640 per ounce. If geopolitical pressure continues to rise, the four trades above could outperform as 2024 wraps up.

Persons: Vladmir Putin, —, DAX, Treasurys, Vladimir Putin's, Peter Boockvar, Cory Kasimov, Robert F, Kennedy Jr, Kasimov Organizations: Dow Jones Industrial, Nasdaq, Global, France's CAC, Bleakley Financial, ISI, Department of Health, Human Services Locations: Ukraine, Russia, Russian, U.S, Europe

☆ Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more
▼ + stars: | 2024-11-15 | by ( Pia Singh | In | ) www.cnbc.com time to read: +3 min

Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. Ulta slipped nearly 3% after Berkshire Hathaway revealed in a regulatory filing that it had sold around 97% of its shares, nearly dissolving its position in the beauty retailer. Berkshire had just bought the stock in the second quarter, making Ulta a relatively new bet. However, the company beat expectations on both lines in the fourth fiscal quarter and issued positive guidance for adjusted earnings per share.

Persons: Donald Trump, Robert F, Kennedy Jr, Eli Lilly, Warren Buffett, Berkshire Hathaway, Ulta, — CNBC's Sean Conlon, Alex Harring, Jesse Pound, Hakyung Kim, Lisa Han Organizations: Global pharma, Moderna, Pfizer, GSK, Novo Nordisk, Nasdaq, Securities and Exchange Commission, Super, New York Stock Exchange, Corp, Berkshire, Pool Corp, AST, Materials, LSEG Locations: China, Domino's, Berkshire

Shares of vaccine makers fell on Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services. Moderna’s stock closed more than 5% lower on Thursday, shares of Novavax fell more than 7% and Pfizer’s stock ended more than 2% lower. Shares of BioNTech, the German drugmaker that helped develop a Covid vaccine with Pfizer, closed more than 6% lower. Shares of those companies dipped further in extended trading as Trump confirmed his pick in a post on his platform Truth Social. Kennedy’s track record as a vaccine skeptic is extensive.

Persons: Donald Trump, Robert F, Kennedy Jr, Trump, Kennedy Organizations: Department of Health, Human Services, Pfizer, GSK, Health, Trump, Moderna, Health Defense Locations: Novavax, British, U.S

☆ Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary
▼ + stars: | 2024-11-14 | by ( Ramishah Maruf | ) edition.cnn.com time to read: +2 min

New York CNN —Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F. Kennedy Jr. to be the next secretary of the Department of Health and Human Services. An hour before the market closed Thursday, as news reports of Trump’s choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6%, and Pfizer fell almost 2%. Novavax, which created a protein-based Covid-19 vaccine, fell almost 6%. Last week, Kennedy said he would “immediately” begin studying vaccine safety and efficacy but promised to not “take vaccines away from anybody.”Other vaccine-related companies also felt the fallout. Over the past year, Pfizer stock has dipped 11%, and Moderna stock has plunged 46%.

Persons: Donald Trump, Robert F, Kennedy Jr, Kennedy, “, Trump, ” Trump, CNN’s Kaitlan Collins, Kristen Holmes, Aaron Pellish Organizations: New, New York CNN, Department of Health, Human Services, Moderna, Pfizer, BioNTech, British GSK, Health, HHS Locations: New York, British

☆ Here are Friday's biggest analyst calls: Nvidia, Apple, Home Depot, Domino's, Wingstop, Warby Parker, Rivian, Bank of America & more
▼ + stars: | 2024-11-08 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Jefferies reiterates Nvidia and Marvell as buy The firm says the two chipmakers still have the most upside. Citi upgrades Bank of America to buy from neutral Citi says the bank could be a beneficiary of lighter regulation. Bank of America downgrades Rivian to neutral from buy Bank of America said it sees regulatory risk under a Trump administration. Bank of America upgrades Teledyne Technologies to buy from neutral The firm says it sees upside ahead for the industrial conglomerate. Goldman Sachs upgrades Wingstop to buy from neutral The firm says the wings restaurant has "best-in-class" growth.

Persons: William Blair, Warby Parker, Bernstein, Apple, Lowe's, Jefferies, Goldman Sachs, Sweetgreen, Goldman, outperformance, it's bullish, BNTX, Oppenheimer, Piper Sandler, Wells, Airbnb, Gross, Trump, TDY Organizations: Apple, Apple Intelligence, Nvidia, Marvell, Enterprise, JPMorgan, China EV, Catalyst, Holdings, Barclays downgrades, Body, Citi, U.S, Deutsche Bank, UBS, Molson Coors, OW, Bank of America, Trump Administration, " Bank of America, Teledyne Technologies Locations: AVGO, 4Q24, DPZ, UW

☆ Stocks making the biggest moves midday: Tesla, Airbnb, Toast, Pinterest and more
▼ + stars: | 2024-11-08 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Pinterest — Shares of the image-sharing platform pulled back 16% after the company issued a lower-than-expected revenue outlook for the current quarter. Block — The Cash App parent company slumped more than 4.5% after its third-quarter revenue of $5.98 billion missed expectations. Toast — The restaurant management company climbed 13% after it forecast adjusted EBITDA of between $90 million and $100 million for the current quarter. Analysts expected a loss of 30 cents per share on $198 million in revenue, according to LSEG. That said, Lucid's net loss widened in the period, posting $992.5 million versus $630.9 million in the year-ago period.

Persons: Donald Trump, Elon, Airbnb, DraftKings, LSEG, Monster, FactSet, Goldman Sachs, — CNBC's Hakyung Kim, Alex Harring, Sean Conlon Organizations: Trump Media & Technology, Arista Networks, Arista, Capri Holdings, Beverage, Barclays

☆ Don't expect Treasury yields to come down significantly anytime soon, says Ned Davis Research
▼ + stars: | 2024-11-08 | by ( Fred Imbert | ) www.cnbc.com time to read: +2 min

Treasury yields have ripped higher of late, even as the Federal Reserve continues to cut rates. The benchmark 10-year Treasury note yield has soared nearly 70 basis points to 4.3% since mid-September, when the Fed cut rates by a half-point. Despite the Fed's latest action, the incoming Trump administration is likely to keep yields elevated, according to Ned Davis Research. Dimitrova noted that rising debt-to-GDP ratio has been closely linked with higher bond yields. The question for investors now is: How long until higher yields start putting pressure on equities?

Persons: Trump, Ned Davis, Veneta, Dimitrova, Goldman Sachs, BNTX Organizations: Federal Reserve, Ned Davis Research

☆ Goldman Sachs upgrades BioNTech to buy, sees stock surging more than 25%
▼ + stars: | 2024-11-08 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +1 min

Goldman Sachs is optimistic on BioNTech as a result of a new oncology asset. The bank upgraded shares of the German biotechnology firm to a buy rating from neutral. Analyst Chris Shibutani accompanied the move by hiking his price target to $137 from $90, which implies upside of $27%. BNTX YTD mountain BNTX YTD chart BioNTech can also support an innovative and expansive clinical development program for BNT327 that could challenge the status quo of immune-oncology regimens, Shibutani added. Of the 19 who cover it, 12 have buy or strong buy ratings on BioNTech, LSEG data shows.

Persons: Goldman Sachs, Chris Shibutani, BNTX

☆ Stocks making the biggest moves premarket: Pinterest, Monster Beverage, Bath & Body Works, Trump Media & more
▼ + stars: | 2024-11-08 | by ( Alex Harring | ) www.cnbc.com time to read: +5 min

Trump Media & Technology Group — Shares of President-elect Donald Trump's media company fell another 4.6% in premarket trading following a 23% plunge in the previous session. The company saw $162 million in revenue, topping the consensus expectation for $150 million. Analysts polled by FactSet penciled in 43 cents in earnings per share and $1.91 billion in revenue. Affirm lost an adjusted 31 cents per share, narrower than the consensus forecast of 35 cents, according to LSEG. Bath & Body Works — The fragrance retailer slid 2.7% in the wake of a Barclays downgrade to underweight from equal weight.

Persons: Donald Trump's, platform's, DraftKings, Sweetgreen, LSEG, Toast, StreetAccount penciling, Versace, Michael Kors, FactSet, BioNTech, Goldman Sachs, Goldman, — CNBC's Sean Conlon, Yun Li, Pia Singh, Samantha Subin Organizations: Trump Media & Technology, LSEG, Arista Networks, Arista, Capri Holdings, Capri, Beverage, Revenue, Barclays Locations: LSEG, BioNTech —

☆ European markets head for mostly positive open as traders gear up for U.S. election
▼ + stars: | 2024-11-04 | by ( Holly Ellyatt | ) www.cnbc.com time to read: +1 min

European markets are expected to start the week on a mostly positive note Monday, with all eyes on Tuesday's presidential election in the U.S. Earnings are set to come from BioNTech and Ryanair and data releases include European manufacturing purchasing managers' index data. Global market aftershocks may hinge heavily on which party takes control of Congress as a result of the vote. If control of the U.S. House of Representatives and Senate is divided, it would likely mean a maintaining of the status quo. Asia-Pacific markets rose Monday, while U.S. stock futures were mixed in overnight trading Sunday.

Persons: Germany's DAX, Donald Trump, Kamala Harris Organizations: U.S, France's CAC, IG, Ryanair, NBC, Global, U.S . House, Republican, Democratic Locations: BioNTech, Asia, Pacific

☆ Earnings playbook: Busiest week of the season includes reports from megacaps Apple and Amazon
▼ + stars: | 2024-10-27 | by ( Fred Imbert | ) www.cnbc.com time to read: +7 min

Monday Ford Motor is set to report earnings after the bell, followed by a conference call at 5 p.m. What history shows: Bespoke Investment Group data shows Ford beats earnings expectations 68% of the time. What to watch: Meta is in a good spot heading into this week's report, according to Bernstein's Mark Shmulik. Microsoft is set to report earnings after the close, with a conference call on deck for 5:30 p.m. Amazon is set to report earnings after the market close, with a conference call at 5 p.m.

Persons: Edison Yu, Yu, BioNTech, Goldman Sachs, Toshiya Hari, Hari, LSEG, Bernstein's Mark Shmulik, Morgan Stanley's Keith Weiss, AAPL, KeyBanc, Justin Post Organizations: Apple, Ford Motor . Pharmaceutical, Pfizer, Corporate America, Monday Ford, LSEG, Ford, AMD, Cloud Service, Google, Microsoft, Windows, CNBC, Management, Amazon Web Services, Bank of America, Amazon Locations: Temu, .

☆ Stocks making the biggest moves premarket: Visa, Starbucks, Salesforce, Lowe's and more
▼ + stars: | 2024-09-24 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Starbucks — The coffee house chain moved 1.6% lower after Jefferies downgraded the stock to underperform from hold and cut its price target. BioNTech — U.S.-listed shares of the German biotechnology company rose 2.7% on the heels of a Morgan Stanley upgrade to overweight from equal weight. Pinterest — The image sharing company rose more than 1% after Oppenheimer initiated coverage of the stock with an outperform rating. GE Vernova — Shares gained nearly 1% after Guggenheim initiated coverage of GE Vernova with a buy rating, saying that it is "still in the early stages of a multi-year improvement in profitability." Analyst Joseph Osha's $300 price target implies a roughly 19% increase from Monday's closing price for the stock.

Persons: Jefferies, Piper Sandler, Lowe's, Oppenheimer, Morgan Stanley, BioNTech, Joseph Osha's, —, Sarah Min, Michelle Fox, Pia Singh, Sean Conlon, Jesse Pound, Fred Imbert Organizations: Thor Industries, Arlo Technologies, Visa, Bloomberg, Justice Department, Citi, Mastercard, Federal Reserve, GE, Guggenheim Locations: U.S, China, —

☆ Here are Tuesday's biggest analyst calls: Nvidia, Apple, Walmart, Salesforce, Starbucks, Amazon & more
▼ + stars: | 2024-09-24 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Here are Tuesday's biggest calls on Wall Street: Piper Sandler initiates Colgate-Palmolive and Church & Dwight as overweight Piper said both consumer products company offer an attractive risk/reward. Piper Sandler upgrades Salesforce to overweight from neutral Piper said it sees an attractive risk/reward for the stock. Bernstein reiterates Amazon as outperform Bernstein said advertising is "key to the bull case once again" for Amazon. Wedbush upgrades Comerica to outperform from neutral The firm added the regional bank to its best ideas list. " CFRA reiterates Nvidia as buy The firm says it sees Nvidia with "sustained compute demand" over the coming years.

Persons: Piper Sandler, Dwight, Piper, Baird, Jefferies, it's bullish, Raymond James reinstates Uber, Raymond James, Goldman Sachs, Goldman, KeyBanc, Morgan Stanley, immuno, Oppenheimer, Lowe's, Redburn, it's, Truist, Baird downgrades McKesson, Needham, Apple, Pinterest, Leerink, Guggenheim, Tesla, TSLA, Bernstein, CFRA Organizations: Colgate, Palmolive, Church, Jefferies, Starbucks, Avidity Biosciences, BP, Exxon, Costco, Walmart, Apple, GE Vernova, UBS, Citi, Mastercard, Visa, U.S, DOJ, Comerica, CMA, Nvidia

☆ Stocks making the biggest moves midday: Visa, Smartsheet, JD.com and more
▼ + stars: | 2024-09-24 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Smartsheet — Shares surged more than 6% after Blackstone and Vista Equity Partners agreed to buy the software maker for $56.50 a share in cash, or about $8.4 billion . Unless another offer is made, the deal is expected to close by January 2025, pending shareholder approval. China stocks — Shares of Chinese companies soared after China's central bank unveiled a host of stimulus measures . Thor earned $1.68 per share on $2.53 billion in revenue in its fiscal fourth quarter. Flowserve — The stock moved nearly 5% higher after Bank of America reiterated a buy rating, saying its exposure to nuclear power is "underappreciated."

Persons: Alibaba, Li, Thor, LSEG, Morgan Stanley, BioNTech, Guggenheim, Joseph, Alex Harring, Samantha Subin, Lisa Kailai Han, Jesse Pound, Sarah Min Organizations: Bloomberg, Justice Department, Blackstone, Vista Equity Partners, JD.com, PDD Holdings, Li Auto, Thor Industries, Arlo Technologies, Bank of America, GE, Joseph Osha Locations: —

☆ Here are Tuesday's biggest analyst calls: Nvidia, Palantir, Amazon, Shopify, Walmart, Microsoft, Palantir, Tesla & more
▼ + stars: | 2024-09-17 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Bank of America reiterates Amazon as buy Bank of America said it's sticking with its buy rating on Amazon following CEO Andy Jassy's letter to employees on Monday. Bank of America adds Palantir to the US1 list Bank of America added the stock to its top picks list. Bank of America reinstates Carvana as buy Bank of America resumed coverage of Carvana and upgraded it to buy saying it sees accelerating growth. Bank of America upgrades Hewlett Packard Enterprise to buy from neutral Bank of America said shares of the company are "attractive." Bank of America upgrades GE Vernova to buy from neutral Bank of America said it sees a "power surge" for the stock.

Persons: Oppenheimer, Andy Jassy's, Andy Jassy, Bernstein, Tesla, underperform Bernstein, Redburn, LSCC, Ford Tamer, Mizuho, DELL, Morgan Stanley, Virgin, Jefferies, it's bullish, JEF, ARMK, Baird, BTIG, " Jefferies, SolarEdge Organizations: Nvidia, " Bank of America, Bank of America, Semiconductor, Stifel, Board, Dell, JPMorgan, ViaSat, United Airlines, Viasat, IFC, Virgin Galactic, Virgin, Citi, UBS, APP, RBC, Baird Conference, Burger, Walmart, Technologies, Healthcare, Barclays, D, WEC, Hewlett Packard Enterprise, of America, Hewlett, Packard Enterprise, GE, Gas Power Services Locations: Europe

Citi lowered its price target on Micron Technology ahead of earnings. The analyst downgraded the solar photovoltaic system stock to underperform from hold and lowered its price target to $17 per share from $27. The firm upgraded the biotechnology stock to buy from hold and raised its price target to $150 per share from $95. The firm initiated coverage of the personal computing and technology stock with an outperform rating and a $135 per share price target. "Shopify holds a significant advantage in the social ecommerce space, with its breadth of direct social media integrations that are crucial for social ecommerce," Ball added.

Persons: Jefferies downgrades SolarEdge Jefferies, Dushyant Ailani, Brian Evans, BioNTech Jefferies, Jefferies, BioNTech, Akash Tewari, Vijay Rakesh, DELL, — Brian Evans, Dominic Ball, Ball, Shopify, Christopher Danely, Danely, Fred Imbert, ~$ ( ~ $ ~$) Organizations: CNBC, Tuesday, Citi, Micron Technology, Jefferies, BNT327, Mizuho, Dell, Mizuho Securities, Micron, MU Locations: Europe, 2024E, China, Monday's

☆ Here are 4 things we're watching closely in the stock market this week
▼ + stars: | 2024-08-04 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Stocks had a rough week, topped off with a pummeling Friday after the July jobs data came in weaker than expected. Until then, bad economic news was good news for the stock market, because it meant the Federal Reserve would start cutting interest rates sooner. On Thursday, a drop in U.S. manufacturing activity for July and a jump in initial jobless claims dragged down the market. Next week is light on economic data, so expect earnings reports and CEO commentaries to drive the market action. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Stocks, Dow Jones, Jim Cramer, would've, Eli Lilly, Mounjaro, Berkshire Hathaway, Krystal, Tyson, BAX, Owens, Walt, Oscar Health, CRON, Krispy, Papa, Jim Cramer's, Jim Organizations: Nasdaq, Dow, Reserve, Broadcom, Devices, Palo Alto, PMI, Wynn Resorts, Investors, Wynn, Wynn Palace, U.S . Disney, Management, and Drug Administration, Carlyle Group, Krystal Biotech, Tyson Foods, TSN, Alpha Metallurgical Resources, BioCryst Pharmaceuticals, Axsome Therapeutics, Technologies, Clover Health, Realty Income Corp, Avis Budget Group, CSX Corp, CSX, Simon Property Group, Sterling Construction Company, Teradata Corp, Yum China Holdings, ZoomInfo Technologies, Holdings, Caterpillar, Baxter International, Vulcan Materials Company, Allegheny Technologies Incorporated, Constellation Energy Group, Marathon Petroleum Corp, Owens Corning Inc, Duke Energy Corp, GXO Logistics, Brands, Builders, Wynn Resorts Ltd, WYNN, Rivian Automotive, Devon Energy Corp, GigaCloud Technology Inc, Lumen Technologies, VF Corp, Walt Disney Co, Novo Nordisk, CVS Health, Aurora Cannabis Inc, Emerson Electric Co, Sony Group Corporation, SONY, Inc, ODP Corporation, Icahn Enterprises, MannKind Corp, ACM Research, Brink's Company, AppLovin Corporation, Digital Turbine, Sarepta Therapeutics, Occidental Petroleum Corp, Bros, SolarEdge Technologies, Aspen, Coeur D'Alene Mines Corp, Co, Vistra Energy, Cheniere Energy, Cronos, Himax Technologies, Properties Trust, Papa John's, Paramount Global, Trade, Lab, B2Gold Corp, Honest Company, Gilead Sciences, Growth, Nikola Corporation, Embraer, New Fortress Energy, Construction, Jim Cramer's Charitable, CNBC, Disney, Pixar Locations: Palo, Macau, Las Vegas, Boston, Vegas, Wynn Macau, China, Novo, Coeur, Gilead

☆ Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
▼ + stars: | 2024-08-01 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

It's Moderna's second-ever commercially available product after its Covid vaccine, which has seen demand plunge as the world emerges from the pandemic and relies less on protective shots and treatments. He added that "we've been having quite intense discussions with governments across Europe" to get Covid vaccine supply from Moderna. He is referring to the European Union's massive renegotiated Covid vaccine supply contract with Pfizer and its German partner BioNTech . Its shares are up nearly 20% this year on increasing confidence around its pipeline and messenger RNA platform, which is the technology used in its Covid vaccine and RSV shot. Moderna is also developing a stand-alone flu shot, a personalized cancer vaccine with Merck and shots for latent viruses, among other products.

Persons: It's Moderna's, Stephane Bancel, we've, Bancel, BioNTech, Moderna, I'm Organizations: Moderna Inc, Moderna, Pfizer, GSK, LSEG, Wall, Research, Merck Locations: Cambridge , Massachusetts, Europe, U.S, Moderna, Ukraine

☆ Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
▼ + stars: | 2024-06-28 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +19 min

But other current employees are dissatisfied with where the strategy shift has left them. In January 2023, Pfizer forecast a steep drop in annual revenue, to between $67 billion and $71 billion. Pfizer's 2023 revenue ultimately came in at $58.5 billion, including $11.22 billion from its Covid vaccine and $1.28 billion from Paxlovid. Faith in executive leadership also plunged among some workers, according to most of the current and former employees who spoke with CNBC. Some current workers said that hasn't appeared to change after the town hall on May 2.

Persons: Albert Bourla, Wall, they're, Bourla, I'm, drugmaker Seagen, Irfan Khan, hasn't, Pfizer, renegotiating, John Thys, Payal Sahni Becher, Becher, Kena, Mike McDermott, Bourla's Organizations: Corbis, Getty, Pfizer, Wall, CNBC, Los Angeles Times, Moderna, Centers for Disease Control, U.S ., GSK, Bristol Myers Squibb, Pfizer wasn't, . Biotech, Companies, Biotech, BioNtech, Reuters, Human, View Press, Global, APEC, Summit, Tech, Google Locations: U.S, Covid, Eagle Rock , California, Durham , North Carolina, Puurs, Belgium, New York City, Peapack , New Jersey, Kena

☆ Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
▼ + stars: | 2024-06-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. Moderna's messenger RNA combination shot, called mRNA-1083, is made up of both the company's vaccine candidate for seasonal influenza and a newer, "next-generation" version of its Covid shot. The study compared the combination shot with an enhanced flu vaccine called Fluzone HD and Moderna's currently licensed Covid shot, Spikevax, in one group of patients ages 65 and above. Moderna is also developing a combination shot targeting the flu and RSV, and another vaccine targeting all three respiratory viruses: Covid, flu and RSV. Meanwhile, Pfizer and BioNTech also are studying a vaccine that targets both Covid and the flu in a late-stage trial.

Persons: Stephane Bancel, Novavax, Bancel, Moderna, BioNTech Organizations: Pfizer, Novavax, Moderna, Covid Locations: U.S

☆ Evercore ISI says three years of biotech underperformance may be ending, gives its 5 favorite stocks
▼ + stars: | 2024-05-14 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

"After 3 years of painful underperformance, winter is finally thawing and spring just might be in the air," analyst Cory Kasimov wrote in a Monday note. Biotech stocks broadly peaked in early 2021 when interest rates were at a trough, Kasimov noted. While biotech stocks are sensitive to interest rates, the analyst believes most of the group's other catalysts — such as mergers and access to capital — remain "relatively consistent." XBI YTD mountain SPDR S & P Biotech ETF performance year to date The sector is opportune for investors looking for "a stock picker's market," according to Kasimov. With this in mind, he named seven stocks to his core initial list, which he named "The Magnificent Seven."

Persons: Cory Kasimov, Kasimov, We've, Neurocrine, — CNBC's Michael Bloom Organizations: ISI, Biotech, P Biotech, Moderna Locations: —

Search resuls for: "BionTech"

25 mentions found